Balchem (BCPC) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Balchem

NasdaqGS•Basic Materials•Specialty Chemicals

$170.62-6.38(-0.04%)After hours

Market Cap

$5.40B

P/E

31.6x

P/S

4.9x

P/B

4.1x

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

How this company scores

ExcellentMetricSide Score: 84/100

Strongest: Profitability (23/25); weakest: Balance Sheet & Red Flags (19/25).

Profitability23/25

Growth19/25

Balance Sheet & Red Flags19/25

Cash & Earnings Quality23/25

Strengths

Strong marginsLow leverageCash-backed earningsConsistent free cash flow

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 31.6x5y range 31.6x – 56.5x

Currently below its 20-quarter median.

P/S · 4.9x5y range 4.7x – 6.8x

Currently near its 20-quarter median.

P/B · 4.1x5y range 3.7x – 6.2x

Price & Volume

Market Cap $5.40B

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.11B
Q. Revenue: $290.66M
TTM EBITDA: $278.39M
TTM Op. Income: $229.57M
Q. Op. Income: $62.44M
TTM Net Income: $170.85M
Q. Net Income: $46.73M
EPS: $1.47
Shares Out.: $31.70M

$1.11B in TTM revenue grew 9.4% YoY, reaching $290.66M last quarter. TTM EBITDA of $278.39M and TTM operating income of $229.57M show growth is flowing through to the bottom line. TTM net income of $170.85M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 36.4%
EBITDA Margin: 25.7%
Op. Margin: 21.5%
Net Margin: 16.1%

Op. margin of 21.5% is up 1.1% YoY — cost efficiency is improving. Net margin at 16.1% and gross margin of 36.4% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 3 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 31.6x
P/S Ratio: 4.9x
P/B Ratio: 4.1x

At 31.6x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 4.9x and P/B of 4.1x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has fallen for 2 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.70B
Cash: $66.26M
Long-Term Debt: $124.00M
Book Value: $1.33B
D/E Ratio: 0.1
Debt/EBITDA: 1.7

With $1.70B in assets and $124.00M in long-term debt, D/E is 0.1and book value is $1.33B — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $69.77M
TTM Free Cash Flow: $178.00M
FCF Margin: 16.1%
FCF / Net Income: 1.0

TTM FCF of $178.00M on $69.77M in operating cash flow. The FCF / Net Income ratio of 1.0x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 10% — an improving trend.